Lanzi C - Search Results

1

Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.

Lopergolo A, Nicolini V, Favini E, Dal Bo L, Tortoreto M, Cominetti D, Folini M, Perego P, Castiglioni V, Scanziani E, Borrello MG, Zaffaroni N, Cassinelli G, Lanzi C. Lopergolo A, et al. Among authors: lanzi c. J Clin Endocrinol Metab. 2014 Feb;99(2):498-509. doi: 10.1210/jc.2013-2574. Epub 2013 Nov 25. J Clin Endocrinol Metab. 2014. PMID: 24276455

2

Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.

Lanzi C, Borrello MG, Bongarzone I, Migliazza A, Fusco A, Grieco M, Santoro M, Gambetta RA, Zunino F, Della Porta G, et al. Lanzi C, et al. Oncogene. 1992 Nov;7(11):2189-94. Oncogene. 1992. PMID: 1437145

3

Protein kinase C activation by anthracyclines in Swiss 3T3 cells.

Lanzi C, Gambetta RA, Perego P, Banfi P, Franzi A, Guazzoni L, Zunino F. Lanzi C, et al. Int J Cancer. 1991 Jan 2;47(1):136-42. doi: 10.1002/ijc.2910470124. Int J Cancer. 1991. PMID: 1845961

4

Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance.

Lanzi C, Perego P, Supino R, Romanelli S, Pensa T, Carenini N, Viano I, Colangelo D, Leone R, Apostoli P, Cassinelli G, Gambetta RA, Zunino F. Lanzi C, et al. Biochem Pharmacol. 1998 Apr 15;55(8):1247-54. doi: 10.1016/s0006-2952(97)00599-6. Biochem Pharmacol. 1998. PMID: 9719480

5

Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative.

Lanzi C, Cassinelli G, Pensa T, Cassinis M, Gambetta RA, Borrello MG, Menta E, Pierotti MA, Zunino F. Lanzi C, et al. Int J Cancer. 2000 Feb 1;85(3):384-90. Int J Cancer. 2000. PMID: 10652431

6

Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin.

Cassinelli G, Lanzi C, Pensa T, Gambetta RA, Nasini G, Cuccuru G, Cassinis M, Pratesi G, Polizzi D, Tortoreto M, Zunino F. Cassinelli G, et al. Among authors: lanzi c. Biochem Pharmacol. 2000 Jun 15;59(12):1539-47. doi: 10.1016/s0006-2952(00)00278-1. Biochem Pharmacol. 2000. PMID: 10799650

7

Structure elucidation of clavilactone D: an inhibitor of protein tyrosine kinases.

Merlini L, Nasini G, Scaglioni L, Cassinelli G, Lanzi C. Merlini L, et al. Among authors: lanzi c. Phytochemistry. 2000 Apr;53(8):1039-41. doi: 10.1016/s0031-9422(99)00506-3. Phytochemistry. 2000. PMID: 10820827

8

A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes.

Cassinelli G, Supino R, Perego P, Polizzi D, Lanzi C, Pratesi G, Zunino F. Cassinelli G, et al. Among authors: lanzi c. Int J Cancer. 2001 Jun 1;92(5):738-47. doi: 10.1002/1097-0215(20010601)92:5<738::aid-ijc1249>3.0.co;2-2. Int J Cancer. 2001. PMID: 11340581

9

Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells.

Lanzi C, Cassinelli G, Cuccuru G, Supino R, Zuco V, Ferlini C, Scambia G, Zunino F. Lanzi C, et al. Prostate. 2001 Sep 15;48(4):254-64. doi: 10.1002/pros.1105. Prostate. 2001. PMID: 11536305

10

Cellular bases of the antitumor activity of the novel taxane IDN 5109 (BAY59-8862) on hormone-refractory prostate cancer.

Cassinelli G, Lanzi C, Supino R, Pratesi G, Zuco V, Laccabue D, Cuccuru G, Bombardelli E, Zunino F. Cassinelli G, et al. Among authors: lanzi c. Clin Cancer Res. 2002 Aug;8(8):2647-54. Clin Cancer Res. 2002. PMID: 12171897

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters